510(k) device
Ceribell Monitor
Ceribell, Inc. · Reduced- Montage Standard Electroencephalograph (OMC, Class II) · First FDA decision Jun 30, 2026, newest Jun 30, 2026Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
5
Naming "Ceribell"
MAUDE reports
1
Brand "Ceribell", since 2015
PubMed studies
29
Mentioning "Ceribell"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ceribell Monitor
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Ceribell Monitor510(k)
K261101 · Decided Jun 30, 2026 · 89 days after receipt
Device type: Reduced- Montage Standard Electroencephalograph (OMC) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Ceribell", any status and sponsor, newest update first.
Ceribell Inc.Not on our public-company list
NCT07449416 · 100 participants (planned) · Start Mar 15, 2026 · Primary completion Oct 2026
Device: Ceribell Delirium Monitoring System · For: Delirium in the Intensive Care Unit
Sites: Irvine, California; Pittsburgh, Pennsylvania
Ceribell Inc.Not on our public-company list
NCT07485244 · 100 participants (planned) · Start Apr 16, 2026 · Primary completion Dec 31, 2026
Device: Ceribell EEG System · For: Delirium in the Intensive Care Unit
Sites: Nashville, Tennessee
- Ceribell Delirium Data Collection StudyRecruiting
Ceribell Inc.Not on our public-company list
NCT04962815 · 200 participants (planned) · Start Nov 10, 2021 · Primary completion Dec 31, 2025
Device: Electroencephalogram (EEG) Test · For: Delirium
Sites: Stanford, California; Naples, Florida; Iowa City, Iowa · 7 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ceribell", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code OMC
8 reports: 6 malfunction, 2 injury, 0 death
Newest reports for this brand
- CERIBELL EEG HEADBAND, SMALL SIZEMalfunction
23582489 · Received Nov 18, 2025 · Event dated Oct 16, 2025
Device type: Full-Montage Standard Electroencephalograph (GWQ)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Ceribell"[tiab]. The summary above synthesizes these.
- Methods of identifying delirium: A research protocol.
Mulkey MA, Hardin SR, Munro CL, et al. · Res Nurs Health · 2019Research Support, Non-U.S. Gov't
- Sensitivity of detecting interictal epileptiform activity using rapid reduced montage EEG.
Freund BE, Tsikvadze M, Feyissa AM, et al. · J Neurol Sci · 2024
- EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report.
Galanopoulou AS, Ferastraoaru V, Correa DJ, et al. · Epilepsia Open · 2020
- Ceribell EEG shortens seizure diagnosis and workforce time and is useful for COVID isolation.
LaMonte MP · Epilepsia Open · 2021
- Cracking the Brain's Black Box: The Rise of Real-Time Neuromonitoring.
Rae-Dupree J · IEEE Pulse · 2025
- Rapid-Response Electroencephalography in Seizure Diagnosis and Patient Care: Lessons From a Community Hospital.
Eberhard E, Beckerman SR · J Neurosci Nurs · 2023
- Monitoring the Burden of Seizures and Highly Epileptiform Patterns in Critical Care with a Novel Machine Learning Method.
Kamousi B, Karunakaran S, Gururangan K, et al. · Neurocrit Care · 2021Research Support, Non-U.S. Gov't
- Improved access to rapid electroencephalography at a community hospital reduces inter-hospital transfers for suspected non-convulsive seizures.
Madill ES, Gururangan K, Krishnamohan P · Epileptic Disord · 2022
- Modeling the economic value of Ceribell Rapid Response EEG in the inpatient hospital setting.
Ney JP, Gururangan K, Parvizi J · J Med Econ · 2021Multicenter Study
- Rapid EEG in Specific Clinical Situations.
Patedakis Litvinov B, Benbadis SR, Hirsch LJ · J Clin Neurophysiol · 2026Review
- Rapid response electroencephalography decreases time to seizure diagnosis in pediatric acute care patients.
Rajan N, Kavanagh T, LaVega-Talbott M, et al. · Epilepsia Open · 2025Observational Study
Other devices of this type
Also filed under product code OMC.
- SignalNED System (Model RE)Forest Devices, Inc. · 510(k) 2025
- REMI Remote EEG Monitoring SystemEpitel · 510(k) 2025
- NX01 (NX01)Naox Technologies Sas · 510(k) 2025
- Natus BrainWatch SystemNatus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · 510(k) 2024
- Quex EdQx World, Ltd. · 510(k) 2024
- NEBA® Compact EEG2R Mobile HeadsetNeba Health, LLC · 510(k) 2023
- Neurosteer EEG RecorderNeurosteer, Inc. · 510(k) 2022
- RemiEpitel, Inc. · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.